Lexicon Resubmits New Drug Application for Sotagliflozin for the Treatment of Heart Failure

Tuesday, May 31, 2022 1 min read

Key Takeaway: Lexicon Resubmits New Drug Application for Sotagliflozin for the Treatment of Heart Failure

Full Press Release Details

Lexicon Resubmits New Drug Application for Sotagliflozin for the Treatment of Heart Failure.